Last edition
News about Digitalization
Novo Nordisk and AWS Partner to Accelerate AI-Driven Drug Discovery
Novo Nordisk and AWS are partnering to accelerate AI-driven drug discovery, with a new London AI hub and AWS becoming Novo Nordisk’s preferred cloud provider.
Digitalization | 12/08/2026 | By News Bureau | 136
Ministry of Ayush and IndiaAI Sign MoU to Advance AI in Traditional Medicine
The Ministry of Ayush and IndiaAI have partnered to advance AI-driven innovation in traditional medicine, research, digital health and AIKosh integration.
Digitalization | 31/07/2026 | By News Bureau | 164
Bristol Myers Squibb Partners with NVIDIA to Build AI Factory
Bristol Myers Squibb and NVIDIA are building an Artificial Intelligence (AI) factory to accelerate drug discovery using advanced AI infrastructure and proprietary life sciences models.
Digitalization | 22/07/2026 | By News Bureau | 147
The initiative aims to equip pharmaceutical companies, biotech firms and research institutions with AI-driven molecular analysis tools to accelerate drug discovery and advance computational biology research.
Digitalization | 17/07/2026 | By News Bureau | 133
Fischer Medical Ventures Strengthens AI Life Sciences Partnership with Nanyang Biologics
Fischer Medical Ventures and Nanyang Biologics are expanding their strategic collaboration to advance Artificial Intelligence (AI)-powered life sciences research and biotechnology innovation in India.
Digitalization | 14/07/2026 | By News Bureau | 158
Evogene and Tel Aviv University Launch AI Drug Discovery Initiative
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery have launched a joint initiative combining Artificial Intelligence (AI)-driven computational chemistry with advanced experimental capabilities to accelerate small-molecule drug discovery.
Digitalization | 08/07/2026 | By News Bureau | 158
SK Bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
SK bioscience has launched an Artificial Intelligence (AI)-powered initiative to improve vaccine development decisions, supporting next-generation injectable rotavirus vaccines and expanding access in Low- and Middle-Income Countries (LMICs).
Digitalization | 04/07/2026 | By News Bureau | 145
Insilico Medicine and Takeda Collaborate on AI Drug Discovery
Takeda and Insilico Medicine are collaborating to advance Artificial Intelligence (AI)-powered drug discovery, leveraging the Pharma.AI platform to accelerate the development of therapeutics.
Digitalization | 02/07/2026 | By News Bureau | 184
IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform
IMU Biosciences has selected Waters to advance its Artificial Intelligence (AI)-powered immune mapping platform, accelerating early disease diagnosis, patient monitoring, and precision medicine development.
Digitalization | 26/06/2026 | By News Bureau | 291
Insilico Medicine and SK Biopharmaceuticals have entered an Artificial Intelligence (AI)-powered drug discovery collaboration worth up to USD 2.5 billion to develop innovative therapies for neuroimmune disorders.
Digitalization | 23/06/2026 | By News Bureau | 485
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy